163 related articles for article (PubMed ID: 15868908)
1. Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium.
Alam S; Bromberg-White J; McLaughlin-Drubin M; Sen E; Bodily JM; Meyers C
Anticancer Res; 2005; 25(2A):765-77. PubMed ID: 15868908
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
[TBL] [Abstract][Full Text] [Related]
3. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification.
Ozbun MA; Meyers C
Virology; 1998 Sep; 248(2):218-30. PubMed ID: 9721231
[TBL] [Abstract][Full Text] [Related]
6. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b.
Ozbun MA; Meyers C
J Virol; 1998 Apr; 72(4):2715-22. PubMed ID: 9525589
[TBL] [Abstract][Full Text] [Related]
7. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.
Frattini MG; Lim HB; Laimins LA
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3062-7. PubMed ID: 8610168
[TBL] [Abstract][Full Text] [Related]
8. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
9. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
Hebner CM; Laimins LA
Rev Med Virol; 2006; 16(2):83-97. PubMed ID: 16287204
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication.
Sen E; McLaughlin-Drubin M; Meyers C
Anticancer Res; 2005; 25(2A):1091-100. PubMed ID: 15868951
[TBL] [Abstract][Full Text] [Related]
11. The transcription map of HPV11 in U2OS cells adequately reflects the initial and stable replication phases of the viral genome.
Isok-Paas H; Männik A; Ustav E; Ustav M
Virol J; 2015 Apr; 12():59. PubMed ID: 25890000
[TBL] [Abstract][Full Text] [Related]
12. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
13. [Virological and carcinogenic aspects of HPV].
Prétet JL; Charlot JF; Mougin C
Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter.
He Y; Huang L
Cancer Res; 1997 Sep; 57(18):3993-9. PubMed ID: 9307284
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: potential treatment for genital warts.
Cowsert LM; Fox MC; Zon G; Mirabelli CK
Antimicrob Agents Chemother; 1993 Feb; 37(2):171-7. PubMed ID: 8383937
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response is hijacked by human papillomaviruses to complete their life cycle.
Hong SY
J Zhejiang Univ Sci B; 2017 Mar; 18(3):215-232. PubMed ID: 28271657
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.
Ozbun MA
J Virol; 2002 Nov; 76(22):11291-300. PubMed ID: 12388689
[TBL] [Abstract][Full Text] [Related]
18. Papillomaviruses as targets for cancer gene therapy.
Shillitoe EJ; Kamath P; Chen Z
Cancer Gene Ther; 1994 Sep; 1(3):193-204. PubMed ID: 7621251
[TBL] [Abstract][Full Text] [Related]
19. Chapter 17: Genital human papillomavirus infections--current and prospective therapies.
Stanley M
J Natl Cancer Inst Monogr; 2003; (31):117-24. PubMed ID: 12807955
[TBL] [Abstract][Full Text] [Related]
20. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication.
Spriggs CC; Laimins LA
mBio; 2017 Feb; 8(1):. PubMed ID: 28196964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
